XML 27 R12.htm IDEA: XBRL DOCUMENT v3.25.4
Significant Consolidated Balance Sheet Components
 12 Months Ended
Dec. 31, 2025
Significant Consolidated Balance Sheet Components [Abstract]  
Significant Consolidated Balance Sheet Components Significant Consolidated Balance Sheet Components
Prepaid expenses and other current assets consisted of the following:
(in millions)
As of December 31,20252024
Prepaid expenses$12.2 $14.6 
Mortgage loans held for sale7.1 2.6 
Income taxes receivable
9.9 0.3 
Contract assets3.5 6.8 
Certificate of deposit2.3 2.2 
Other current assets0.4 1.7 
Total prepaid expenses and other current assets$35.4 $28.2 
Property, equipment and software, net consisted of the following:
(in millions)
As of December 31,20252024
Capitalized software development costs
$
99.1 
$
124.6 
Office equipment
3.9 
4.2 
Furniture and fixtures
0.9 
1.4 
Leasehold improvements
1.4 
2.3 
Total property, equipment and software
105.3 
132.5 
Accumulated depreciation and amortization
(73.5)
(89.5)
Total property, equipment and software—net
$
31.8 
$
43.0 
The Company capitalized $20.4 million, $24.3 million and $34.0 million of software development costs, and recorded amortization expense of $31.2 million, $32.8 million and $28.9 million, during 2025, 2024 and 2023, respectively. No losses on disposal related to software development costs were recorded in 2025, 2024 or 2023.
Depreciation and amortization, exclusive of amortization of capitalized software development costs and intangible assets, was $1.6 million, $2.2 million and $2.3 million in 2025, 2024 and 2023, respectively.
During 2025, the Company made a strategic investment of $2.0 million in equity interests of a limited liability company. These equity interests are accounted for under the equity method of accounting. In applying the equity method of accounting, investments are initially recorded at cost, and subsequently adjusted based on the Company’s proportionate share of the investee’s net income or loss, based on the most recent available financial information from the investee, net of any contributions and distributions received. Equity method investments are periodically reviewed for impairment, and would be considered impaired when the fair value of the Company’s interest is less than the carrying value, with an impairment charge recorded in earnings if such decline in value is determined to be other than temporary. Equity method investments are included in other assets on the Company’s consolidated balance sheet. The carrying value of the Company’s equity method investment was $2.0 million as of December 31, 2025, and there were no related changes in carrying amount or impairment during 2025.
Accrued expenses and other current liabilities consisted of the following:
(in millions)
As of December 31,20252024
Unbilled accounts payable$46.9 $33.7 
Accrued compensation6.0 4.8 
Income taxes payable
0.5 3.1 
Warehouse line of credit
6.9 2.5 
Operating lease liabilities1.9 2.3 
Other accrued expenses3.3 4.8 
Total accrued expenses and other current liabilities$65.5 $51.2 
Other liabilities—noncurrent consisted of the following:
(in millions)
As of December 31,20252024
Operating lease liabilities$6.1 $4.1 
Unrecognized tax benefit liability
9.6 8.8 
Other noncurrent liabilities— 0.4 
Total other liabilities—noncurrent$15.7 $13.3